Skip to main content
NASDAQ:DBTX

Decibel Therapeutics News Headlines

$6.53
-0.53 (-7.51 %)
(As of 05/17/2021 12:00 AM ET)
Add
Compare
Today's Range
$6.38
$7.08
50-Day Range
$6.39
$12.23
52-Week Range
$6.18
$24.39
Volume58,099 shs
Average Volume142,161 shs
Market Capitalization$162.61 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Decibel Therapeutics (NASDAQ DBTX) News Headlines Today

SourceHeadline
Decibel Therapeutics (NASDAQ:DBTX) Releases  Earnings Results, Misses Expectations By $0.55 EPSDecibel Therapeutics (NASDAQ:DBTX) Releases Earnings Results, Misses Expectations By $0.55 EPS
americanbankingnews.com - May 14 at 12:22 PM
Decibel Therapeutics (NASDAQ:DBTX) Price Target Cut to $18.00Decibel Therapeutics (NASDAQ:DBTX) Price Target Cut to $18.00
americanbankingnews.com - May 14 at 11:40 AM
Decibel Therapeutics Reports First Quarter 2021 Financial Results and Corporate UpdateDecibel Therapeutics Reports First Quarter 2021 Financial Results and Corporate Update
finance.yahoo.com - May 13 at 10:27 PM
How Many Decibel Therapeutics, Inc. (NASDAQ:DBTX) Shares Do Institutions Own?How Many Decibel Therapeutics, Inc. (NASDAQ:DBTX) Shares Do Institutions Own?
finance.yahoo.com - May 12 at 7:55 AM
Decibel Therapeutics, Inc. (NASDAQ:DBTX) Given Average Rating of "Buy" by AnalystsDecibel Therapeutics, Inc. (NASDAQ:DBTX) Given Average Rating of "Buy" by Analysts
americanbankingnews.com - May 11 at 11:08 PM
Decibel Therapeutics to Present at the American Society of Gene and Cell Therapy 24th Annual MeetingDecibel Therapeutics to Present at the American Society of Gene and Cell Therapy 24th Annual Meeting
finance.yahoo.com - April 28 at 12:35 PM
Decibel Therapeutics (NASDAQ:DBTX) Trading Down 2.5%Decibel Therapeutics (NASDAQ:DBTX) Trading Down 2.5%
americanbankingnews.com - April 23 at 12:38 AM
Decibel Therapeutics to Present at the 20th Annual Needham Virtual Healthcare ConferenceDecibel Therapeutics to Present at the 20th Annual Needham Virtual Healthcare Conference
finance.yahoo.com - April 8 at 12:28 PM
Decibel Therapeutics Added to Russell 2000 IndexDecibel Therapeutics Added to Russell 2000 Index
finance.yahoo.com - March 22 at 10:16 AM
News for Decibel Therapeutics Inc Registered ShsNews for Decibel Therapeutics Inc Registered Shs
markets.businessinsider.com - March 12 at 9:12 PM
DBTX.O - Decibel Therapeutics Inc Profile | ReutersDBTX.O - Decibel Therapeutics Inc Profile | Reuters
reuters.com - March 11 at 9:32 AM
Decibel Therapeutics to Present at the Barclays Global Healthcare ConferenceDecibel Therapeutics to Present at the Barclays Global Healthcare Conference
finance.yahoo.com - March 4 at 8:43 AM
Decibel Therapeutics Presents Promising Preclinical Findings on DB-OTO, Gene Therapy Product Candidate Designed to Provide Hearing to Individuals with Otoferlin MutationsDecibel Therapeutics Presents Promising Preclinical Findings on DB-OTO, Gene Therapy Product Candidate Designed to Provide Hearing to Individuals with Otoferlin Mutations
finance.yahoo.com - February 24 at 10:13 AM
Decibel Therapeutics to Present at the 44th Annual Association for Research in Otolaryngology (ARO) ConferenceDecibel Therapeutics to Present at the 44th Annual Association for Research in Otolaryngology (ARO) Conference
finance.yahoo.com - February 19 at 7:30 AM
Decibel Therapeutics IncDecibel Therapeutics Inc
reuters.com - February 16 at 1:14 PM
This page was last updated on 5/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.